Lin Shao-Lee
Reporting owner on Forms 3, 4 and 5, CIK 1725092.
Lin Shao-Lee reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-14.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| CUE · Cue Biopharma, Inc.CIK 1645460 | director, officer (Chief Executive Officer) | 1 | 2026-10-14 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| CUE · Cue Biopharma, Inc.Common Stock | 2026-10-12 | S sold | -10,000 | $27.5 | 695,995 | Form 4 |
| CUE · Cue Biopharma, Inc.Common Stock | 2026-10-12 | S sold | -1,087 | $28.05 | 694,908 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001725092-26-000019 | Cue Biopharma, Inc. | 2026-10-14 |